dc.creatorTrovero, A.
dc.creatorMazza, Mariana
dc.creatorRogé, Ariel
dc.creatorRivas, María Cristina
dc.creatorBordagorria, Ximena L.
dc.creatorBruno, Susana B
dc.creatorDavel, Graciela Odelsia
dc.date2020-12-04T09:10:23Z
dc.date2020-12-04T09:10:23Z
dc.date2020
dc.date.accessioned2023-08-29T20:07:32Z
dc.date.available2023-08-29T20:07:32Z
dc.identifier0325-7541
dc.identifierhttp://sgc.anlis.gob.ar/handle/123456789/1822
dc.identifier10.1016/j.ram.2019.06.002
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/8519713
dc.descriptionFil: Trovero, A. ANLIS Dr. C. G. Malbrán. Instituto Nacional de Producción de Biológicos. Servicio antígenos y antisueros; Argentina.
dc.descriptionFil: Mazza, Mariana. ANLIS Dr.C.G.Malbrán. Instituto Nacional de Enfermedades Infecciosas. Departamento de Micología; Argentina.
dc.descriptionFil: Rogé, Ariel. ANLIS Dr. C. G. Malbrán. Instituto Nacional de Producción de Biológicos. Servicio antígenos y antisueros; Argentina.
dc.descriptionFil: Rivas, María Cristina. ANLIS Dr.C.G.Malbrán. Instituto Nacional de Enfermedades Infecciosas. Departamento de Micología; Argentina.
dc.descriptionFil: Bordagorria, Ximena L. ANLIS Dr. C. G. Malbrán. Instituto Nacional de Producción de Biológicos. Servicio antígenos y antisueros; Argentina.
dc.descriptionFil: Bruno, Susana B. ANLIS Dr. C. G. Malbrán. Instituto Nacional de Producción de Biológicos. Servicio antígenos y antisueros; Argentina.
dc.descriptionFil: Davel, Graciela Odelsia. ANLIS Dr.C.G.Malbrán. Instituto Nacional de Enfermedades Infecciosas. Departamento de Micología; Argentina.
dc.descriptionCryptococcosis is a fungal disease affecting more than one million people per year worldwide. Its main etiological agents are Cryptococcus neoformans species complex and Cryptococcus gattii species complex. Cryptococcal meningitis (CM) is considered an AIDS-defining condition. Rapid diagnosis by cryptococcal antigen assays, either the latex agglutination test (LA) or the lateral flow assay, is key to decreasing mortality due to cryptococcal disease. The aim of the study was to develop a latex agglutination reagent (LA-ANLIS) for the rapid and reliable diagnosis of cryptococcosis in Argentina. This reagent will be produced in order to supply the NMLN (National Mycology Laboratory Network). The evaluation of LA-ANLIS performance and its comparison with the Cryptococcus Antigen Latex Agglutination Test System (LA-IMMY) (Immuno-Mycologics, Inc., USA) were conducted in 94 samples of cerebrospinal fluid. LA-ANLIS and LA-IMMY compared exhibited 100% positive agreement and 97% negative agreement. LA-ANLIS showed 94% sensitivity and 97% specificity with the positive and negative predictive values of 94% and 97%, respectively. The LA-ANLIS is a reliable, reproducible and cost-effective reagent, especially useful in countries where the commercial kit is not generally available and must be obtained at a high cost. National production of reagents is the best choice for a reliable access to the rapid diagnosis of CM in Argentina.
dc.formatpdf
dc.languageen
dc.relationRevista Argentina de microbiologia
dc.rightsopen
dc.sourceRevista Argentina de Microbiología 2020;52(3):169-175
dc.subjectLátex
dc.subjectMeningitis Criptocócica
dc.subjectCriptococosis
dc.subjectCryptococcus gattii
dc.subjectCryptococcus neoformans
dc.titleProduction of a latex agglutination reagent for the rapid diagnosis of cryptococcal meningitis
dc.typeArtículo


Este ítem pertenece a la siguiente institución